| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/27/2005 | EP1082143B1 Mr signal-emitting coatings |
| 07/27/2005 | CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/27/2005 | CN1646173A Microparticles comprising carbohydrate beads covalently linked with allergen |
| 07/26/2005 | US6921825 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/26/2005 | US6921533 Method of using monoclonal antibodies against leukocyte adhesion receptor β-chain |
| 07/26/2005 | US6921525 Diagnosis of cardiovascular disorders |
| 07/26/2005 | CA2272432C Testkit and method |
| 07/21/2005 | WO2005066629A1 Retinal toxicity screening methods |
| 07/21/2005 | WO2005065725A1 Polymeric marker with high radiopacity for use in medical devices |
| 07/21/2005 | WO2005065724A1 Formulations of paramagnetic ion complexes |
| 07/21/2005 | WO2005065723A1 RAPID SCREENING METHODS FOR FUNCTIONAL p53 USING THE RESPONSE PATTERN TO ARSENIC TRIOXIDE |
| 07/21/2005 | WO2005065721A2 Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex |
| 07/21/2005 | WO2005065686A1 Differentiation modulating agents and uses therefor |
| 07/21/2005 | WO2005065241A2 Smmr (small molecule metabolite reporters) for use as in vivo glucose biosensors |
| 07/21/2005 | WO2005065079A2 Medical implants and fibrosis-inducing agents |
| 07/21/2005 | WO2005065041A2 Display for computer-aided evaluation of medical images and for establishing clinical recommendation therefrom |
| 07/21/2005 | WO2005046722A3 Carbohydrate antigen-nanoparticle conjugates and uses thereof as antimetastatic agents in treating cancer |
| 07/21/2005 | WO2005045039A9 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/21/2005 | WO2005001415A3 Optically pure and enriched isomers of chelating ligands and contrast agents |
| 07/21/2005 | WO2004090109A3 Ccn3 compositions and methods |
| 07/21/2005 | WO2003074005A8 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 07/21/2005 | US20050158608 Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself |
| 07/21/2005 | US20050158393 Polymeric material associated with colloidal metal particles, especially gold, suitable for injection or implantation |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | US20050158274 Therapeutic use of a fibrosing agent to induces a fibrotic response at a specific site, thereby providing the patient with pulmonary sealing |
| 07/21/2005 | US20050158272 Depositing a liquid embolic composition of polyethylene glycol diacrylate (PEGDA), pentaerythritol tetra(3-mercaptopropionate), in a buffer into a lumen; curing by cross-linking or polymerization |
| 07/21/2005 | US20050158242 Detecting presence of selected cancer by measuring levels of Cancer Specific Genes(CSG) in cells, tissues or bodily fluids and comparing levels with levels of CSG from normal human control, wherein change in measured levels is associated with presence of selected cancer; gynecologic and lung cancers |
| 07/21/2005 | US20050158241 Novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 07/21/2005 | US20050158239 Perturbed membrane-binding compounds and methods of using the same |
| 07/21/2005 | CA2550312A1 Retinal toxicity screening methods |
| 07/20/2005 | EP1553984A1 Production of a dye for colouring cells in the human or animal body |
| 07/20/2005 | EP1553963A1 Novel agents that modulate eph receptor activity |
| 07/20/2005 | EP1553926A2 Surface dissolution and/or bulk erosion controlled release compositions and devices |
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1553923A1 Camptothecin-carboxylate formulations |
| 07/20/2005 | EP1553904A2 Topical patch preparation kit containing a delayed-type hypersensitivity inducer |
| 07/20/2005 | EP1047677B1 Process for the preparation of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid |
| 07/20/2005 | EP0871431B1 Hepatocyte-selective oil-in-water emulsion |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1211128C Supersonic development agent for gastrointestinal tract and its preparing method |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | US6919068 Porous ultrasound contrast agents prepared by freezing both phases of an oil-in-water suspension and removing the frozen phases by sublimation |
| 07/14/2005 | WO2005064338A1 Microparticles for use in diagnostic methods |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063306A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 07/14/2005 | WO2005063305A1 Gas-filled microvesicle assembly for contrast imaging |
| 07/14/2005 | WO2005063304A2 Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent |
| 07/14/2005 | WO2005063010A1 A novel use of neuroactive compounds |
| 07/14/2005 | WO2005063009A1 A procedure for screening of neuroactive substance and the associated neural plasticity |
| 07/14/2005 | WO2005021494A9 D-amino acid peptides |
| 07/14/2005 | WO2004091375A3 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 07/14/2005 | WO2004078927A3 Progenitor cells and methods of using same |
| 07/14/2005 | WO2004069179A3 Improved thickened beverages for dysphagia |
| 07/14/2005 | US20050155087 Method of screening compounds |
| 07/14/2005 | US20050154537 Methods, program products, and systems for single and multi-agent dosing and other related methods |
| 07/14/2005 | US20050154271 Integrated receiver for continuous analyte sensor |
| 07/14/2005 | US20050154185 Vitronectin receptor antagonist pharmaceuticals |
| 07/14/2005 | US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis |
| 07/14/2005 | US20050153940 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 07/14/2005 | US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 07/14/2005 | US20050152960 Photodynamic therapy; age-related macular degeneration; liposomes |
| 07/14/2005 | US20050152878 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 07/14/2005 | US20050152876 administering PTX3 to increase the amount or activity of Pentraxin 3 in the cumulous oophorus and/or the extracellular matrix of the cumulous oophorus |
| 07/14/2005 | US20050152843 Heat pressing a mixture of an active ingredient with abuse potential, a high strength polymer, and a wax into a controlled release dosage form; cannot be dispersed or even dissolved in such a manner that it may safely be administered parenterally, in particular intravenously |
| 07/14/2005 | US20050152842 Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent |
| 07/14/2005 | US20050152840 hydrogenation apparatus comprising chambers having liquid outlet into conduits leading to liquid drop generators, intakes to a solvent removal chamber, hydrogen intakes, catalyst removal chamber, gas and liquid discharges |
| 07/14/2005 | US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal |
| 07/14/2005 | US20050152837 Novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 07/14/2005 | CA2547024A1 Gas-filled microvesicle assembly for contrast imaging |
| 07/14/2005 | CA2545362A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 07/13/2005 | EP1552794A2 Apparatus for marking tissue |
| 07/13/2005 | EP1552741A1 Non-human mammal model comprising heterologous nucleated cells-use for screening compounds |
| 07/13/2005 | EP1552739A1 Hepatic cirrhosis model animal and method of constructing the same |
| 07/13/2005 | EP1551990A2 Diagnosis and treatment of chemoresistant tumors |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551478A1 Threaded syringe with quick stop |
| 07/13/2005 | EP1551461A2 Azo compounds for type i phototherapy |
| 07/13/2005 | EP1551459A1 Microbubble compositions, and methods for preparing and using same |
| 07/13/2005 | EP1551292A2 Method for convection enhanced delivery of therapeutic agents |
| 07/13/2005 | EP1303313B1 Meted hyperpolarized noble gas dispensing methods and associated devices |
| 07/13/2005 | CN1639566A Therapeutic properties of oils |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1638811A Use of 13C labelled substance for measuring lung function |
| 07/13/2005 | CN1638810A Near infrared fluorescent contrast agent and method for fluorescence imaging |
| 07/13/2005 | CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 07/13/2005 | CN1636601A Construction process of Alzhemer's disease rat animal model |
| 07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
| 07/12/2005 | US6916799 Antiinflammatory agents; respiratory system disorders |
| 07/12/2005 | US6916625 Artery- and vein-specific proteins and uses therefor |
| 07/12/2005 | US6916461 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis |
| 07/12/2005 | CA2283518C Diagnostic agents for pancreatic exocrine function |
| 07/12/2005 | CA2201012C Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media |
| 07/12/2005 | CA2175584C Method of monitoring patient compliance with medications prescriptions |
| 07/07/2005 | WO2005061725A1 Methods for detecting markers associated with endometrial disease or phase |
| 07/07/2005 | WO2005061724A1 Self-assembling nanoparticle conjugates |
| 07/07/2005 | WO2005061456A1 Near-infrared fluorescent contrast medium |
| 07/07/2005 | WO2005061008A1 Bowel preparation for virtual colonscopy |
| 07/07/2005 | WO2005060739A1 Transgenic non-human mammal comprising a polynucleotide encoding human or humanized c5ar |
| 07/07/2005 | WO2005047493A3 Nanofibrillar structure and applications including cell and tissue culture |